AGI-14100
Product Specifications
CAS Number
1448346-43-7
Target
Dehydrogenase, Isocitrate Dehydrogenase (IDH)
Related Pathways
Metabolism
Purity
>99.99%
Bioactivity
AGI-14100 is a novel and orally available mIDH1 inhibitor.AGI-14100 is used for the treatment of primary human myeloid leukemia.
Smiles
N([C@H](C(NC1CC(F)(F)C1)=O)C2=C(Cl)C=CC=C2)(C(=O)[C@H]3N(C(=O)CC3)C4=CC(C#N)=CC=N4)C5=CC(F)=CC(F)=C5
Molecular Formula
C29H22ClF4N5O3
Molecular Weight
599.96
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1144427-01 0.05 mg (E-Coli)
Recombinant Laccaria bicolor Adenylosuccinate synthetase 1 (LACBIDRAFT_295311)
Sign In for Pricing
View Details MBS1144427-02 0.05 mg (Yeast)
Recombinant Laccaria bicolor Adenylosuccinate synthetase 1 (LACBIDRAFT_295311)
Sign In for Pricing
View Details MBS1144427-03 0.05 mg (Baculovirus)
Recombinant Laccaria bicolor Adenylosuccinate synthetase 1 (LACBIDRAFT_295311)
Sign In for Pricing
View Details MBS1144427-04 0.2 mg (E-Coli)
Recombinant Laccaria bicolor Adenylosuccinate synthetase 1 (LACBIDRAFT_295311)
Sign In for Pricing
View Details MBS1144427-05 0.5 mg (E-Coli)
Recombinant Laccaria bicolor Adenylosuccinate synthetase 1 (LACBIDRAFT_295311)
Sign In for Pricing
View Details MBS1144427-06 0.2 mg (Yeast)
Recombinant Laccaria bicolor Adenylosuccinate synthetase 1 (LACBIDRAFT_295311)
Sign In for Pricing
View Details